ASCP HTL Exam Prep
By the Castleport Test Prep Editorial Team · Last verified November 3, 2026
For HTL(ASCP) testing dates from November 1, 2026 onward, ASCP uses a revised HT/HTL content guideline, and everything below is built on it. Start with the map of what's HTL-only, then work the 30 practice questions; each answer and explanation sits under its question.
Where the exam is weighted — and what's HTL-only
The HTL exam is 100 questions in 2 hours 30 minutes, across the same five areas as the HT exam (ASCP guideline, p. 1). What separates HTL is the set of outline lines marked "HTL ONLY" (pp. 2–6).
| Content area | Share of exam | HTL-only lines in the current guideline |
|---|---|---|
| Staining | 30–40% | IHC/IF staining theory, antigen retrieval techniques, selection of controls, antibody preparation, detection theory; enzyme histochemistry staining; ISH (FISH, CISH) staining; dye chemistry principles; refractive index of mounting media |
| Fixation | 15–25% | Chemistry principles of fixative reagents |
| Embedding/ |
15–25% | Preparation for molecular testing (e.g., RNase-free area, scrolls) |
| Processing | 10–20% | Chemistry principles of processing reagents |
| Laboratory Operations | 10–15% | Basic management principles (hiring, discipline, job descriptions, evaluations, scheduling); basic education principles (learning objectives, teaching methods, performance evaluations) |
Everything else in the outline is tested on both HT and HTL, and that shared core is most of the exam. The shared-core checklist further down covers it.
Start here today:
- Work the 30 questions below without notes.
- Sort every miss into the error log by area and by reason.
- Pick the 6-week plan or its 3- or 10-week version.
- Keep the current ASCP guideline open as your checklist.
30 practice questions for the HTL exam
Original, unofficial practice questions written by Castleport Test Prep. They are not ASCP questions. They are weighted toward HTL-level topics and spread across all five areas in roughly the guideline's proportions. Your score on them is feedback on these 30 items, not an ASCP scaled score or a prediction of passing.
Fixation
HTL-PREP-001
Which statement correctly contrasts how 10% neutral buffered formalin (NBF) and ethanol fix tissue?
Show answer for question 1
Answer: C. Formalin penetrates quickly, but the cross-linking reactions that actually fix proteins are slower than penetration, which is why fixation time matters. Alcohol works differently: it coagulates and precipitates proteins, dehydrates and hardens tissue, and can extract small molecules such as low-molecular-weight carbohydrates. A practical consequence: alcohol-fixed tissue generally doesn't need antigen retrieval, while formalin-fixed tissue often does. A swaps alcohol into the cross-linking group; B reverses the mechanisms; D describes neither. Source: Dako/Agilent IHC Guidebook, 6th ed., Ch. 2, pp. 23–24.
HTL-PREP-002
A lumpectomy sat unrefrigerated in the operating room for about 4 hours before being placed in 10% NBF. HER2 immunohistochemistry (IHC) later shows poor morphology and patchy loss of membrane staining. Which statement is most accurate?
Show answer for question 2
Answer: B. Degradation starts when tissue loses its blood supply. Published guidance calls for cold ischemic time of one hour or less, and deterioration of an epitope from ischemia can't be recovered with antigen retrieval. In the guidebook's HER2 example, staining actually increases at 1–2 hours of cold ischemia and much of it is lost by 4 hours, so delayed fixation can push results either way. A and C treat a preanalytic problem with analytic fixes; D can't rebuild degraded protein. Sources: Dako/Agilent IHC Guidebook, Ch. 2, pp. 21–22, Fig. 2.2; CAP/ASCO 2023 HER2 guideline update.
HTL-PREP-003
A breast core biopsy for estrogen receptor (ER) testing has been in 10% NBF for 3 hours when the evening processor run is being loaded. Under ASCO/CAP fixation recommendations for ER/PgR and HER2, the best action is to:
Show answer for question 3
Answer: D. ASCO/CAP recommends fixation in 10% NBF for 6 to 72 hours for these breast markers. Tissue that spends only a few hours in NBF before processing ends up partly fixed by the processor's alcohols — a non-standardized mix that can give false negative or false positive results. A, B and C all ship under-fixed tissue. (The guidebook's authors argue for at least 24 hours in NBF as best practice; the 6–72 hour window is the ASCO/CAP requirement.) Sources: Dako/Agilent IHC Guidebook, Ch. 2, pp. 23–24; CAP/ASCO 2020 ER/PgR guideline update; CAP/ASCO 2023 HER2 guideline update.
HTL-PREP-004
Cells fixed in glutaraldehyde for an indirect immunofluorescence study show bright, diffuse green background, even on a slide that received no primary antibody. Which step most directly addresses the cause?
Show answer for question 4
Answer: A. Aldehyde fixation — glutaraldehyde especially — produces autofluorescence. Washing fixed cells with 0.1% sodium borohydride before antibody incubation reduces it, as does choosing probes and filters that maximize signal over autofluorescence. More secondary (B) adds signal to a background problem. Hydrogen peroxide (C) blocks peroxidase, which plays no part in fluorescence detection. Longer excitation (D) speeds photobleaching of the real signal. Source: Dako/Agilent IHC Guidebook, Ch. 6, p. 89.
HTL-PREP-005
A lab is evaluating microwave-enhanced fixation to shorten turnaround. Which concern is best supported?
Show answer for question 5
Answer: C. Microwave and ultrasound methods speed fixation by generating heat, but results can be uneven depending on specimen size, composition and the microwave used, and direct microwaving coagulates protein and can harden tissue. A change in fixation protocol is one of the listed triggers for validation. A overstates the effect; B is invented; D contradicts the validation requirement. Source: Dako/Agilent IHC Guidebook, Ch. 2, pp. 25, 28.
HTL-PREP-006
A tonsil fixed after a long delay is stained for kappa light chains. Plasma cells stain, but so does interstitial tissue and plasma inside vessels. The most likely explanation is:
Show answer for question 6
Answer: B. When the target is abundant in blood plasma, it can diffuse into surrounding tissue before fixation. The antibody then binds real antigen in the wrong place — "unwanted specific staining." Prompt fixation and properly diluted antisera reduce it. Biotin (A) produces granular cytoplasmic background in biotin-rich cells, not a plasma pattern. Chromogen granules (C) look like scattered precipitate. Fc receptor background (D) is more common in frozen sections, smears and lightly fixed tissue. Source: Dako/Agilent IHC Guidebook, Ch. 15, pp. 174–175.
Processing
HTL-PREP-007
After the processor's paraffin stations were raised to 68 °C to speed infiltration, IHC intensity drops across many antibodies while H&E looks acceptable. The best corrective action is to:
Show answer for question 7
Answer: D. Immunoreactivity can be diminished or destroyed during embedding when paraffin is too hot; the troubleshooting guidance is wax melting around 55–58 °C, not exceeding 60 °C. Lower-melting waxes have been reported to give better IHC results than higher-melting ones. A, B and C push the detection system harder to hide a preanalytic cause. Sources: Dako/Agilent IHC Guidebook, Ch. 2, p. 25; Ch. 16, p. 182.
HTL-PREP-008
Dozens of tiny biopsies are processed together each night, each held between foam sponges. The processor is showing reagent carryover between stations. The best change is to:
Show answer for question 8
Answer: A. Sponges absorb and retain processing fluids more than tissue does, so large numbers of sponge-containing cassettes can carry reagent from one container to the next. Nylon biopsy bags don't retain significant reagent and are recommended. B makes carryover worse; C skips dehydration, so paraffin can't infiltrate; D adds load without addressing retention. Source: Dako/Agilent IHC Guidebook, Ch. 2, p. 26.
HTL-PREP-009
To make small biopsies easier to see at embedding, a lab wants to tint them during processing. FISH may be ordered on some of these cases. Which tint should be avoided?
Show answer for question 9
Answer: C. Mercurochrome has been observed to diminish or abolish the FISH signal and add background fluorescence, and it shouldn't be used anyway for safety reasons (it contains mercury). Adding a little alcoholic eosin has not appeared to harm later IHC or ISH, though any biopsy-coloring step should be tested before use — which also rules out D. B is safe but doesn't solve the visibility problem. Source: Dako/Agilent IHC Guidebook, Ch. 2, p. 26.
Embedding/Microtomy
HTL-PREP-010
Why do positively charged slides hold formalin-fixed sections especially well?
Show answer for question 10
Answer: B. Positively charged slides attract the negative charges on tissue proteins. Formalin blocks amino groups, which leaves tissue more acidic and more negatively charged — so adhesion is especially good after formalin fixation. Paraffin (A) is removed before staining; C reverses the charge; D isn't how adhesion works. Source: Dako/Agilent IHC Guidebook, Ch. 2, p. 25.
HTL-PREP-011
A pathologist requests 10 µm scrolls from three different patients' blocks for DNA sequencing. Which practice best prevents cross-contamination?
Show answer for question 11
Answer: D. Molecular assays can amplify small amounts of contaminating nucleic acid, so the sectioning workflow should minimize carryover between blocks. Use a clean new blade, clean forceps, fresh gloves, a pre-labeled tube, and a decontaminated microtome work surface for each specimen. A leaves material on the shared edge; B adds an unnecessary handling step; C invites both contamination and identification errors. Source: OHSU Dermatopathology Services — FFPE molecular specimen requirements.
HTL-PREP-012
Unstained sections for HER2 IHC were cut 8 weeks ago and stored at room temperature. The best action is to:
Show answer for question 12
Answer: C. Blocks are relatively stable, but cut sections exposed to air can lose immunoreactivity, and the guidance for HER2 is not to use sections more than 6 weeks old. Fresh sections remove the variable. A is false for cut slides; B adds heat damage; D tries to correct an unknown loss. Sources: Dako/Agilent IHC Guidebook, Ch. 2, p. 25; Ch. 16, p. 182.
HTL-PREP-013
IHC slides show irregular, blotchy unstained patches. The deparaffinizing xylene hasn't been changed during a week of heavy use. The most likely cause and fix are:
Show answer for question 13
Answer: A. Wax must be fully removed so aqueous antibodies and detection reagents can reach the tissue. The guidebook puts xylene's practical limit at about 50 slides per 50 mL before residual wax causes artifacts; incomplete dewaxing appears in the troubleshooting chart with the fix "fresh xylene or substitute." B, C and D don't produce wax-shaped skips. Sources: Dako/Agilent IHC Guidebook, Ch. 2, pp. 25–26; Ch. 16, p. 183.
HTL-PREP-014
Which statement about cutting unfixed frozen tissue in a cryostat is correct?
Show answer for question 14
Answer: B. Unfixed frozen tissue can contain viable human pathogens or toxins, so precautions must be used. Formalin inactivates the large majority of pathogens that might contaminate tissue — prions are the exception. A and C get the risk backward; D is the classic trap. Source: Dako/Agilent IHC Guidebook, Ch. 2, p. 27.
Staining
HTL-PREP-015
Why does heat-induced epitope retrieval (HIER) restore staining for many formalin-fixed antigens?
Show answer for question 15
Answer: D. Formalin modifies proteins so antibodies may no longer recognize them. Studies from the 1940s showed formalin–protein cross-links can be disrupted by heating above 100 °C, which led to HIER in 1991. Heat plus water is the critical combination: sections in pure glycerin and heated stain negative, but adding water and heating again gives satisfactory staining. Retrieval solution pH matters too, but heating is the dominant factor. A, B and C describe other steps or nothing real. Source: Dako/Agilent IHC Guidebook, Ch. 3, pp. 31–32.
HTL-PREP-016
A new antibody arrives with no protocol for your staining platform. What is the most efficient way to establish its retrieval method?
Show answer for question 16
Answer: B. The test battery screens the two biggest variables — retrieval pH and heating condition — on a small number of slides. A simplified version compares common solutions such as citrate pH 6 and Tris-EDTA pH 9. Higher-pH solutions suit most antigens, so A is wrong. Proteolytic pretreatment (C) is harder to control, and the digestion it needs scales with how long the tissue was fixed. D ignores masked epitopes. Sources: Dako/Agilent IHC Guidebook, Ch. 2, p. 24; Ch. 3, pp. 32–34.
HTL-PREP-017
A kidney section stained with an avidin–biotin complex (ABC) method shows granular cytoplasmic staining in tubular epithelium. The negative reagent control shows the same pattern. The best fix is to:
Show answer for question 17
Answer: C. Staining that also appears on the negative reagent control isn't coming from the primary antibody. Kidney tubules, liver and lymphoid tissue contain endogenous biotin, which avidin- and streptavidin-based systems will detect. Blocking means avidin first, then biotin to fill the extra binding sites the avidin adds. Polymer systems avoid the problem entirely. A blocks peroxidase and B blocks alkaline phosphatase — neither is the source here. D can't fix something the primary isn't causing. Sources: Dako/Agilent IHC Guidebook, Ch. 6, p. 80; Ch. 15, p. 173.
HTL-PREP-018
A small-bowel section is stained with an alkaline phosphatase (AP) detection system and a red chromogen, with 5 mM levamisole in the substrate. The brush border is still red on the negative reagent control. The best next step is:
Show answer for question 18
Answer: A. Levamisole quenches most forms of endogenous AP, but the intestinal form resists it. Intestinal AP can be quenched with a weak acid wash before the primary antibody. B repeats the treatment that doesn't work on this isoenzyme; C targets peroxidase; D targets biotin. Source: Dako/Agilent IHC Guidebook, Ch. 15, p. 172.
HTL-PREP-019
A mouse monoclonal antibody that used to stain well becomes weak after the lab moves its 3% hydrogen peroxide block to right after HIER and immediately before the primary antibody. Other antibodies are unaffected. The best fix is to:
Show answer for question 19
Answer: D. Some epitopes are altered by the peroxidase blocking reagent. The guidebook describes a CD4 clone that's significantly impaired when a standard 3% hydrogen peroxide block follows HIER and comes right before the primary. The block can be applied at any point after the primary and before the enzyme-labeled components. A and B don't address the cause, and C risks endogenous peroxidase background in blood-rich tissue. Sources: Dako/Agilent IHC Guidebook, Ch. 4, pp. 48–49; Ch. 16, p. 182.
HTL-PREP-020
An IHC stain developed with AEC looks bright red before coverslipping. After dehydration through alcohols, clearing in xylene and mounting in a resinous medium, the red is gone. Why?
Show answer for question 20
Answer: B. AEC produces a red end-product that's soluble in organic compounds, so the manufacturer specifies a nonalcoholic counterstain and an aqueous-based mounting medium. DAB, by contrast, is a permanent chromogen that survives dehydration and resinous mounting. A isn't the issue; C is irrelevant once the product has formed; D doesn't remove color. Sources: Agilent/Dako AEC+ Substrate-Chromogen package insert; Dako/Agilent IHC Guidebook, Ch. 16, p. 182.
HTL-PREP-021
A mouse monoclonal IgG1 primary antibody is used with a biotin-based detection system. Which is the most appropriate negative reagent control?
Show answer for question 21
Answer: A. The negative reagent control replaces only the primary antibody, so any staining it produces comes from somewhere else — endogenous activity, detection reagents, or the tissue. The optimal substitute matches isotype, concentration and diluent. Diluent alone (C) is described as neither efficient nor desirable. B is a negative tissue control, which tests specificity in a different way. D doesn't mirror the patient-slide protocol. With biotin-free polymer systems, CAP lets the laboratory director decide whether a negative reagent control can be omitted. Source: Dako/Agilent IHC Guidebook, Ch. 14, pp. 162–164.
HTL-PREP-022
A breast carcinoma fixed for about 80 hours shows no ER staining. Normal breast ducts in the same section are also completely negative. How should this result be treated?
Show answer for question 22
Answer: C. Normal breast ducts weakly express ER, which makes them a built-in positive control that went through exactly the same fixation and staining as the tumor. ASCO/CAP defines ER negative as less than 1% staining in the presence of positive intrinsic controls, and flags negative results without internal control elements on samples fixed outside 6–72 hours. A ignores the failed control; B invents a result; D can't fix a slide that's already stained. Sources: Dako/Agilent IHC Guidebook, Ch. 14, p. 166; CAP/ASCO 2020 ER/PgR guideline update.
HTL-PREP-023
Frozen sections of a normal human muscle biopsy are reacted for myofibrillar ATPase after preincubation at pH 9.4 and at pH 4.3. Which pattern is expected?
Show answer for question 23
Answer: B. Preincubation pH inactivates the myosin ATPase of particular fiber types. Alkaline preincubation (pH 9.4) leaves type 2 fibers dark and type 1 light; acid preincubation (pH 4.3) reverses the pattern, with type 1 dark and types 2A and 2B light. Type 2C fibers stay intermediate at pH 4.3. At pH 4.6, type 2B is intermediate, which is how 2A and 2B are told apart. The method depends on active enzyme, which is why it's done on frozen tissue. C reverses the pattern; A and D would show no fiber-type contrast. Sources: Washington University Neuromuscular Disease Center, ATPase method; Behan et al., J Clin Pathol 2002.
HTL-PREP-024
In a dual-color HER2 chromogenic in situ hybridization (CISH) assay read by bright-field microscopy, what serves as the internal positive control for the staining process and pre-analytical handling?
Show answer for question 24
Answer: D. Normal cells in the section went through the same fixation, processing and hybridization as the tumor, so they act as an internal positive control. CEN-17 (A) is the reference probe used to calculate the HER2/CEN-17 ratio — in the method described, at least 20 nuclei are counted. B supports morphology, and C preserves the signals; neither checks the assay. Source: Dako/Agilent IHC Guidebook, Ch. 13, p. 155.
HTL-PREP-025
Why is a resinous medium dissolved in xylene preferred for permanently mounting most stained sections?
Show answer for question 25
Answer: A. Glass has a refractive index of about 1.52. When the mounting medium matches it, light passes without diffraction at the boundaries and the section looks completely transparent. Resinous media in xylene or toluene come very close; aqueous media usually have a lower refractive index, which reverses D. Resinous media need dehydration and clearing first (not B), and they don't change the dyes (not C). Source: StainsFile, Mounting Media.
HTL-PREP-026
You need 400 µL of a primary antibody at a 1:200 working dilution (1 part concentrate in 200 total parts). How do you prepare it?
Show answer for question 26
Answer: C. Concentrate = total volume ÷ dilution factor = 400 µL ÷ 200 = 2 µL. Diluent = 400 − 2 = 398 µL. A is the common trap: adding 2 µL to a full 400 µL makes 402 µL at 1:201. B is 1:20, and D is 1:100. Check which convention your lab's procedure uses — "1 part in 200 total" here — before you pipette.
Laboratory Operations
HTL-PREP-027
Under the CLIA histopathology standard, how often must fluorescent and immunohistochemical stains be checked for positive and negative reactivity?
Show answer for question 27
Answer: B. CLIA requires fluorescent and immunohistochemical stains to be checked for positive and negative reactivity each time of use. For other special stains, a control slide of known reactivity must be stained with each patient slide or group of patient slides. All control procedures must be documented. A, C and D are too infrequent. Source: 42 CFR 493.1273(a), (f).
HTL-PREP-028
A newly hired technologist starts performing high-complexity IHC in January. Under CLIA, how often must her competency be evaluated and documented?
Show answer for question 28
Answer: D. For high-complexity testing, CLIA requires evaluation at least semiannually in the first year, then at least annually, with reevaluation before reporting when methodology or instrumentation changes. The evaluation must include six elements: direct observation of routine testing (including specimen handling and processing); monitoring recording and reporting of results; review of worksheets, QC, proficiency testing and maintenance records; direct observation of instrument maintenance and function checks; testing previously analyzed specimens, blind samples or PT samples; and assessment of problem-solving skills. Source: 42 CFR 493.1451(b)(8)–(9).
HTL-PREP-029
Your lab receives an external proficiency testing (PT) challenge for IHC. A coworker suggests calling a colleague at the system's sister hospital lab to compare interpretations before submitting. Under CLIA, this is:
Show answer for question 29
Answer: A. PT samples must be tested with the regular patient workload, by the personnel who routinely do the testing, using routine methods. Inter-laboratory communication about PT results is prohibited until after the reporting deadline — including across a lab's own sites. Sending PT samples to another lab for testing the lab is certified to perform can lead to revocation of certification. B, C and D invent exceptions. Source: 42 CFR 493.801(b)(1), (4), (5).
HTL-PREP-030
You're writing objectives for training a new hire on the rotary microtome. Which objective is written in the psychomotor domain?
Show answer for question 30
Answer: C. Bloom's taxonomy groups learning into three domains: cognitive (knowledge and thinking), affective (attitudes and values) and psychomotor (manual or physical skills). C describes an observable hands-on skill. A is cognitive; B is affective. D isn't a usable performance objective at all, because "understand" isn't observable or measurable. Sources: SSCC Center for Excellence in Teaching and Learning, Bloom's Taxonomy; Carnegie Mellon University Eberly Center, Learning Objectives.
Sort your misses
Total your correct answers by area — Fixation /6, Processing /3, Embedding/
Then put every miss in one of four buckets. The bucket tells you what to do next.
| Why you missed it | What it means | What to do |
|---|---|---|
| You didn't know the fact | Knowledge gap | Read the cited source section and make one flashcard for it |
| You knew the topic but mixed up two methods or reagents | Two things blur together | Build a side-by-side comparison (for example, levamisole vs weak acid wash, or AEC vs DAB) |
| You misread the stem | Reading gap | Redo it, and before looking at the options, say what the question is actually asking |
| You picked a reasonable answer that wasn't the best one | Judgment gap | Write one sentence on why the right answer fits the stem's exact conditions better |
Finally, flag which misses came from HTL-only lines (items 001, 011, 015–026, 028 and 030). Those are your HTL-specific gaps.
What changed for HTL on November 1, 2026
ASCP's HTL content guideline page assigns one guideline to testing dates through October 31, 2026 and a revised one to dates from November 1, 2026. The exam model didn't change: 100 questions, 2 hours 30 minutes, CAT, one best answer, and the same five areas and percentages. The outline did. Compare the current guideline with the previous one.
| Area | What changed | What it means for HTL candidates |
|---|---|---|
| IHC/immunofluorescence | Split into named sub-lines. HTL-only: staining theory, antigen retrieval techniques, selection of controls, antibody preparation, and newly listed detection theory. HT keeps terminology | Study avidin–biotin vs polymer detection, endogenous enzyme and biotin blocking, controls, and dilutions as part of this HTL-only layer |
| Molecular prep | "Laser capture microdissection" removed from the examples; RNase-free area and scrolls remain (HTL only) | Focus on contamination control and scroll handling |
| Special stains | HTL-only "preliminary screening of histochemical special stains" removed; "Function" removed under staining tissues; Hall bile stain added to the stain list | Drop screening drills; add Hall stain |
| Pathology and biochemistry | No longer HTL-only under Fixation and Staining tissues — now tested on both exams | Still needed for HTL; HT candidates now share it |
| Regulations | No longer HTL-only. Expanded to quality assurance, validation of tests/controls/instruments, proficiency testing and competency assessment, HIPAA, inventory, and procedure writing | Regulations are now shared content; management and education remain separately marked HTL ONLY |
| Management and education | Still HTL-only, now titled "Basic Management Principles" (hiring, discipline, job descriptions, evaluations, scheduling) and "Basic Education Principles" (learning objectives, teaching methods, performance evaluations) | Learn the vocabulary of objectives and evaluations |
| Safety | Six short lines became a detailed outline: SDS, spill response, PPE, exposure monitoring (TWA, STEL, PEL), fire classes, ergonomics, infection control | Same for both exams |
| Fixatives | New named list: acetone, alcohol, Bouin, Carnoy, formalin (10% NBF, alcoholic, zinc), glutaraldehyde, Michel medium, Zamboni | Same for both exams |
| Lab math and processing | "Metric system" became "Unit conversions"; "Calcified/decalcified tissue" became "Decalcification"; special stains added under processing | Minor relabeling |
If your materials follow the 2019 guideline or the October 2026 version, most content still applies. The gaps to fill are IHC detection theory, the expanded regulations and safety lines, the fixative list, and Hall stain.
Your 6-week HTL study plan
Time assumption: about 6–8 focused hours a week. That's our editorial starting point for someone who already works in histology or holds HT, not an ASCP requirement. Keep every area in light rotation every week.
| Week | Focus | Study tasks | Practice | End-of-week check |
|---|---|---|---|---|
| 1 | Fixation and processing, with chemistry | Fixative mechanisms, ASCP's fixative list, fixation time and cold ischemia, paraffin and processing reagents, decalcification | Redo HTL-PREP-001–009 cold; explain each answer out loud | Can you explain cross-linking vs coagulation, and why under-fixed breast tissue fails ER? |
| 2 | Embedding/microtomy and molecular prep | Slide adhesion, section storage, dewaxing, frozen sections and safety, scrolls and contamination control | Redo 010–014; write one question per instrument | Could you train someone to cut molecular scrolls? |
| 3 | IHC I: retrieval and detection | HIER vs proteolytic retrieval, test battery, ABC/LSAB vs polymer, endogenous peroxidase/AP/biotin blocking, chromogens | Redo 015–020 | For each background pattern, can you name the cause and the block? |
| 4 | IHC II, enzyme histochemistry, ISH | Controls (positive, negative tissue, negative reagent, internal), antibody dilution, ATPase and oxidative enzymes, FISH vs CISH | Redo 021–026; do five dilution problems of your own | Can you defend a control choice and calculate any dilution? |
| 5 | Special stains and mounting | Work the guideline's stain list by target; refractive index and mounting media; Hall stain | Use the HT page's stain table as flashcards | For each stain: target, color, and one way it fails |
| 6 | Lab operations and mixed review | CLIA QC, competency, PT; management and education vocabulary; safety outline; lab math | Redo 027–030, then all 30 in random order; clear your error log; run the before-test-day checklist | Every error-log entry re-explained without notes |
Other timelines:
- 3 weeks: pair Weeks 1+2, 3+4 and 5+6. Do a short mixed set every day.
- 10 weeks: give IHC three weeks, spread special stains over two, and add a weekly mixed-retrieval session.
If you've already failed once: a failed ASCP score report breaks your score down by content area (ASCP Examination Results). Build the plan around your two weakest areas and keep the rest on review.
The shared core: don't skip it
It's easy to pour your hours into the HTL-only layer and let the routine material slide. Check yourself against this list:
- Fixation: the guideline's named fixatives (acetone, alcohol, Bouin, Carnoy, formalin in 10% NBF/alcoholic/zinc forms, glutaraldehyde, Michel medium, Zamboni), fixation time, pigments and artifacts
- Processing: dehydration, clearing, infiltration, decalcification, processor troubleshooting
- Embedding/
Microtomy: orientation, paraffin and frozen sectioning, section artifacts, instrument care - Staining: H&E and the routine special stains by target (carbohydrates, connective tissue, microorganisms, pigments and minerals, nerve, lipids, bone marrow), including the newly listed Hall bile stain
- Laboratory Operations: safety (SDS, PPE, spills, TWA/STEL/PEL, fire classes), lab math and unit conversions, QA, validation, proficiency testing, competency, HIPAA, inventory, procedures
Our ASCP HT exam prep page has detailed stain and fixative tables for this shared layer. This page spends its depth on what HTL adds.
The HTL-only layer, explained
Immunohistochemistry: retrieval, detection, blocking and controls
Retrieval. Formalin modifies proteins so some epitopes are masked. HIER uses heat in an aqueous solution to reverse that; heating condition and pH are the main variables. Citrate pH 6 is widely used, high-pH solutions suit most antigens, and new antibodies should be screened with a test battery. Proteolytic digestion (trypsin, pepsin, proteinase K) is harder to control, because the digestion it needs scales with fixation time (Dako/Agilent IHC Guidebook, Ch. 3).
Detection.
| System | How it works | Watch for |
|---|---|---|
| Direct | Label on the primary antibody | Low sensitivity |
| Indirect | Labeled secondary binds the primary | Secondary must match the primary's species |
| ABC / LSAB | Biotinylated secondary + avidin/streptavidin–enzyme | Endogenous biotin (liver, kidney, lymphoid tissue; higher in frozen sections) |
| Polymer | Dextran backbone carrying secondary antibodies and many enzyme molecules | Biotin-free; very large conjugates need thorough washing |
| Tyramide (CSA) | Peroxidase deposits many tyramide labels near the target | Very sensitive; background rises with signal |
Source: Dako/Agilent IHC Guidebook, Ch. 6, pp. 79–82.
Blocking endogenous activity.
| Problem | Typical block |
|---|---|
| Endogenous peroxidase (red cells, granulocytes) | 3% hydrogen peroxide, 5–10 minutes |
| Endogenous alkaline phosphatase | 5 mM levamisole in substrate; intestinal AP needs a weak acid wash |
| Endogenous biotin | Avidin, then biotin — or use polymer detection |
Source: Dako/Agilent IHC Guidebook, Ch. 15, pp. 172–173.
Controls.
| Control | What it is | What it proves |
|---|---|---|
| Positive tissue control | Tissue with known, stable antigen — ideally including low-expression structures | The protocol ran correctly and is sensitive |
| Negative tissue control | Tissue (or regions) lacking the antigen | Specificity |
| Negative reagent control | Primary replaced by matched isotype or non-immune serum at the same concentration | Staining isn't coming from non-primary sources |
| Internal (built-in) control | Normal elements in the patient section that express the antigen | Preanalytic and staining handling of that specific specimen |
On-slide controls catch missing reagents on that slide; batch controls don't. Source: Dako/Agilent IHC Guidebook, Ch. 14, pp. 162–166.
Chromogens. DAB gives a permanent brown product. AEC gives red but dissolves in alcohol and organic solvents, so it needs aqueous mounting (Agilent AEC+ insert).
Enzyme histochemistry
Staining questions on enzyme histochemistry are HTL-only; fixation and processing questions for these methods appear on both exams (ASCP guideline, p. 5). The stain list names ATPase, cytochrome oxidase, succinic dehydrogenase, NADH, esterase and acid phosphatase. For ATPase fiber typing, know the reversal (WUSTL):
| Preincubation pH | Type 1 | Type 2A | Type 2B | Type 2C |
|---|---|---|---|---|
| 9.4 | Light | Dark | Dark | Dark |
| 4.6 | Dark | Light | Intermediate | Intermediate |
| 4.3 | Dark | Light | Light | Intermediate |
In situ hybridization
Both exams cover fixation and processing for ISH; staining questions are HTL-only (ASCP guideline, p. 6). FISH uses fluorescent probes and a fluorescence microscope. CISH converts the signals to chromogens readable by bright-field with a hematoxylin counterstain. In the dual-color HER2 method described by Dako, the HER2/CEN-17 ratio is counted in at least 20 nuclei, and normal cells serve as the internal control (Dako/Agilent IHC Guidebook, Ch. 13, p. 155).
Preparation for molecular testing
Change blades and gloves between specimens, use clean forceps to put scrolls directly into labeled tubes, wipe the water bath between samples, and clean surfaces with nuclease-removing agents (NCI BRD SOP).
Mounting and refractive index
Glass is about 1.52. Resinous media in xylene come close and make preparations fully transparent; aqueous media have a lower refractive index and are used when a stain or chromogen can't survive dehydration (StainsFile).
Management, education and regulations
- Competency (CLIA, high complexity): six required elements; semiannual in year one, then annual (42 CFR 493.1451).
- Histopathology QC: IHC and fluorescent stains checked for positive and negative reactivity each time of use; documented (42 CFR 493.1273).
- Proficiency testing: test like patient specimens; no inter-lab communication before the deadline; no referral (42 CFR 493.801).
- Learning objectives: use observable, measurable actions; cognitive, affective and psychomotor domains are commonly used to organize learning objectives (SSCC CETL; Carnegie Mellon Eberly Center).
HTL exam at a glance
| Item | Detail |
|---|---|
| Credential | Scientist in Histotechnology, HTL(ASCP); HTL(ASCPi) is a separate international credential with distinct eligibility requirements |
| Exam owner | ASCP Board of Certification (ASCP BOC) |
| Where | Pearson testing centers |
| Format | 100 multiple-choice questions, four options, one best answer |
| Time | 2 hours 30 minutes |
| Method | Computer adaptive testing (CAT); questions from all areas appear throughout |
| Skipping | You must answer each question before moving on; you can flag questions and review them if time remains |
| Calculator | On-screen calculator provided |
| Unscored items | Field-test questions are mixed in and look the same as scored ones |
| Scoring | Scaled score from 100 to 999; minimum passing score 400 |
| Results | Preliminary pass/fail on screen; an email to view your official score report within four business days, once transcripts are processed |
| Application fee | $260, non-refundable |
| Attempts | Up to five under one eligibility route |
Sources: ASCP About the Examination; ASCP Examination Results; ASCP Application Policies; ASCP HTL credential page.
Practicing for a CAT exam: a right answer brings a slightly harder question and a wrong one a slightly easier question. Your score reflects the whole response pattern, so there's no fixed number or percentage to hit — and ASCP warns that missing questions on purpose backfires (About the Examination). Use practice to find and fix gaps, answer every item without skipping, and pace yourself at about 90 seconds per question.
Myth: "The passing score is 400, so I need 40% right." Fact: 400 is a point on ASCP's 100–999 scaled score, not a percentage. Because the exam adapts to you, ASCP says there's no fixed number or percentage of correct answers that guarantees a pass (About the Examination).
Before test day
- Recheck the guideline. Open ASCP's HTL content guideline page and confirm your date falls under the November 1, 2026 version.
- Check your eligibility window. Your Admission Notification shows the period you must test within. ASCP doesn't extend eligibility periods (Application Policies).
- Confirm your Pearson appointment. Date, time and center, using ASCP's schedule or reschedule page.
- Read the ID and test-center rules fresh. Use the current ASCP and Pearson instructions, not a friend's memory of them.
- Last two days: error log only. Re-explain your misses. Don't start new material.
Who can take HTL(ASCP)
ASCP decides eligibility only after a paid application, and eligibility periods aren't extended (Application Policies). Every U.S. route requires a baccalaureate degree (ASCP HTL credential page):
- Route 1: Bachelor's degree with 30 semester hours (45 quarter hours) of biology and chemistry combined (both required), plus a NAACLS-accredited histotechnician or histotechnologist program completed within the last 5 years.
- Route 2: Bachelor's with a biological science or chemistry major, or the 30 semester hours of biology and chemistry; plus, within the last 5 years, one of: 1 year of full-time clinical histopathology experience; 1 year of full-time veterinary, industry or research histopathology experience in the U.S. or Canada; or a structured histology program of at least 9 months with at least 480 clinical hours.
- Route 3: Valid HT(ASCP), a bachelor's degree, and 6 months of full-time clinical histopathology experience (or veterinary, industry or research experience in the U.S. or Canada) within the last 5 years.
- Route 4: Bachelor's with the 30 semester hours of biology and chemistry, plus a 50-week U.S. military histotechnician course completed within the last 10 years.
Experience under Routes 2 and 3 must cover every listed area — fixation, processing, embedding/microtomy, staining including IHC, and laboratory operations — and be documented on ASCP's forms. ASCP and ASCPi credentials have distinct eligibility requirements; candidates should choose the credential whose requirements they actually meet rather than choosing solely by location. Check yours with ASCP's Eligibility Assistant, then see ASCP exam registration for the steps.
Common questions
Is the HTL exam the same as the HT exam? They share one guideline, the same five areas, and the same percentages. HTL adds the HTL-only lines in the table at the top of this page. If you're actually sitting HT, use our ASCP HT exam prep page.
What does ASCP recommend reading? ASCP's HT/HTL suggested reading list, reviewed June 2026, flags several titles as more appropriate for the HTL level: Dabbs's Diagnostic Immunohistochemistry, Kiernan's Histological and Histochemical Methods, Garcia's Clinical Laboratory Management, and Harmening's Laboratory Management. ASCP says the list is only a partial reference and that exam content isn't drawn solely from it. The Dako IHC guidebook cited throughout this page is on the list and free from Agilent.
What if I don't pass? Your score report will break your score down by content area. You can sit up to five times under one route. See ASCP exam results and ASCP exam retake policy.
How many people pass? Our ASCP pass-rate research includes HTL rows from ASCP's published data. Pass rates describe groups of test takers; they can't predict your result.
How do I keep the credential? Through ASCP's Credential Maintenance Program. See ASCP certification maintenance program.
Want more shared-core practice? The free ASCP HT practice test covers the routine stains, fixation and processing that both exams test.
Sources
Last verified: November 3, 2026. We rechecked the content-guideline date boundary, exam format and scoring, results timing, attempt policy, eligibility routes and fee, and reading list against current ASCP pages. Practice-item sources were also rechecked where accessible; current CAP/ASCO guidance replaces the older ER/PgR citation, and the molecular-scroll and learning-objective sources were repaired where the original links were no longer suitable.
- ASCP BOC. HT/HTL Examination Content Guideline, valid for testing dates beginning November 1, 2026. Revised July 10, 2026; pp. 1–6.
- ASCP BOC. HT/HTL Examination Content Guideline, valid for testing dates up to and including October 31, 2026. Revised July 10, 2026; pp. 1–5.
- ASCP BOC. Scientist in Histotechnology – HTL Content Guideline (date selector).
- ASCP BOC. Scientist in Histotechnology – HTL route requirements.
- ASCP BOC. About the Examination.
- ASCP BOC. Examination Results.
- ASCP BOC. Application Policies.
- ASCP BOC. HT/HTL Suggested Reading. Reviewed June 2026.
- Taylor CR, Rudbeck L (eds.). Immunohistochemical Staining Methods (IHC Guidebook), 6th ed. Agilent Technologies.
- Agilent/Dako. AEC+ Substrate-Chromogen package insert.
- CAP/ASCO. Estrogen and Progesterone Receptor Testing in Breast Cancer Guideline Update. Update published 2020.
- CAP/ASCO. HER2 Testing in Breast Cancer — 2023 Guideline Update.
- Washington University Neuromuscular Disease Center. ATPase method.
- Behan WMH et al. Validation of a simple, rapid, and economical technique for distinguishing type 1 and 2 fibres. J Clin Pathol, 2002.
- StainsFile. Mounting Media.
- OHSU Dermatopathology Services. FFPE molecular specimen requirements.
- 42 CFR 493.1273, Standard: Histopathology.
- 42 CFR 493.1451, Standard: Technical supervisor responsibilities.
- 42 CFR 493.801, Condition: Enrollment and testing of samples.
- Southern State Community College CETL. Bloom's Taxonomy of Educational Objectives.
- Carnegie Mellon University Eberly Center. Learning Objectives.
- ASCP BOC. Schedule or Reschedule Your Examination.
Castleport Test Prep is an independent exam prep publisher. We are not affiliated with, endorsed by, or approved by the American Society for Clinical Pathology (ASCP) or the ASCP Board of Certification. HTL(ASCP), HT(ASCP) and other credential names are used only to identify the exams discussed; trademarks belong to their respective owners. The practice questions on this page are original and are not official exam questions. Passing is not guaranteed.